Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2006; 12(20): 3283-3287
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3283
Figure 2
Figure 2 Representative images of HER-2 immunoreactivity in (A) moderately differentiated intestinal type adenocarcinoma (score 3), (B) poorly differentiated intestinal type adenocarcinoma (score 3), and (C) chronic gastritis (score 1).